Picato (LEO Pharma Inc.)
Welcome to the PulseAid listing for the Picato drug offered from LEO Pharma Inc.. This Cell Death Inducer [EPC],Increased Cellular Death [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | LEO Pharma Inc. |
| NON-PROPRIETARY NAME: | ingenol mebutate |
| SUBSTANCE NAME: | INGENOL MEBUTATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cell Death Inducer [EPC],Increased Cellular Death [PE] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-01-23 |
| END MARKETING DATE: | 0000-00-00 |
Picato HUMAN PRESCRIPTION DRUG Details:
| Item Description | Picato from LEO Pharma Inc. |
| LABELER NAME: | LEO Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(ug/g) |
| START MARKETING DATE: | 2012-01-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50222-502_ce9c6324-f7f6-4bd0-bbde-8f7efde5b725 |
| PRODUCT NDC: | 50222-502 |
| APPLICATION NUMBER: | NDA202833 |
Other INGENOL MEBUTATE Pharmaceutical Manufacturers / Labelers:
